USCOM Ltd
UCM
Company Profile
Business description
USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. The company generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology.
Contact
Level 8, 66 Clarence Street
Suite 2
SydneyNSW2000
AUST: +61 292474144
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
11
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,833.60 | 4.90 | 0.06% |
CAC 40 | 7,734.90 | 3.52 | -0.05% |
DAX 40 | 23,807.50 | 17.39 | 0.07% |
Dow JONES (US) | 44,484.42 | 10.52 | -0.02% |
FTSE 100 | 8,810.10 | 35.41 | 0.40% |
HKSE | 24,069.94 | 151.47 | -0.63% |
NASDAQ | 20,393.13 | 190.24 | 0.94% |
Nikkei 225 | 39,785.90 | 23.42 | 0.06% |
NZX 50 Index | 12,704.48 | 79.81 | -0.62% |
S&P 500 | 6,227.42 | 29.41 | 0.47% |
S&P/ASX 200 | 8,595.80 | 1.90 | -0.02% |
SSE Composite Index | 3,461.15 | 6.36 | 0.18% |